MEDP Medpace Holdings, Inc.

NASDAQ
$618.88

Medpace Holdings, Inc. (MEDP) is confirmed to report earnings on October 21, 2026, after the market close. The consensus earnings estimate is $4.45 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -4.4% since its last earnings release on July 22, 2026.

Medpace Missed Expectations, Raises Earnings Guidance
Wednesday, July 22, 2026 · 4:15 PM ET
Earnings Date
3rd Quarter, Sep 2026
Oct 21
Wednesday · 4:15 PM ET
Earnings Whisper
-
vs $4.45
Rev est $708.75M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $597.71

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Medpace Holdings, Inc.

Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries.

Sector

Healthcare

Industry

Research Services

Held By 2 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.